Phathom Pharmaceuticals, Inc. Common Stock (NASDAQ: PHAT) last traded at $8.87, up 3.14% on the session. The quote above updates while this page is open; the figures below are drawn from Phathom Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Phathom Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker PHAT. Its market capitalisation is $717.59 million.
Valuation measures for Phathom Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $717.59M |
|---|---|
| Enterprise value | $1.21B |
| Price / sales | 2.99 |
| Beta | 0.58 |
Trailing-twelve-month figures tagged in Phathom Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $239.66M |
|---|---|
| Net income (TTM) | -$99.07M |
| EPS (TTM) | -$1.25 |
| Gross margin | 82.92% |
| Operating margin | -16.96% |
| Cash | $182.48M |
Range and volume for PHAT over the past 52 weeks.
| 52-week high | $18.31 |
|---|---|
| 52-week low | $8.21 |
| Volume | 969.2K |
| Average volume | 1.32M |
| Previous close | $8.60 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.